Arcturus Therapeutics Holdings Stock Technical Analysis
ARCT Stock | USD 27.93 0.87 3.22% |
As of the 24th of April, Arcturus Therapeutics shows the mean deviation of 3.22, and Risk Adjusted Performance of (0.02). Arcturus Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Arcturus Therapeutics Holdings, which can be compared to its peers. Please confirm Arcturus Therapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Arcturus Therapeutics is priced correctly, providing market reflects its regular price of 27.93 per share. Given that Arcturus Therapeutics has information ratio of (0.07), we suggest you to validate Arcturus Therapeutics Holdings's prevailing market performance to make sure the company can sustain itself at a future point.
Arcturus Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Arcturus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ArcturusArcturus |
Arcturus Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
54.5 | Strong Buy | 10 | Odds |
Most Arcturus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Arcturus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arcturus Therapeutics, talking to its executives and customers, or listening to Arcturus conference calls.
Arcturus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Arcturus Therapeutics Technical Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Arcturus Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Arcturus Therapeutics Trend Analysis
Use this graph to draw trend lines for Arcturus Therapeutics Holdings. You can use it to identify possible trend reversals for Arcturus Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Arcturus Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Arcturus Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Arcturus Therapeutics Holdings applied against its price change over selected period. The best fit line has a slop of 0.15 , which may suggest that Arcturus Therapeutics Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 808.4, which is the sum of squared deviations for the predicted Arcturus Therapeutics price change compared to its average price change.About Arcturus Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Arcturus Therapeutics Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Arcturus Therapeutics Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Arcturus Therapeutics price pattern first instead of the macroeconomic environment surrounding Arcturus Therapeutics. By analyzing Arcturus Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Arcturus Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Arcturus Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2022 | 2023 | 2024 (projected) | Payables Turnover | 19.2 | 0.56 | 0.53 | Days Of Inventory On Hand | 1.23E-4 | 1.11E-4 | 1.17E-4 |
Arcturus Therapeutics April 24, 2024 Technical Indicators
Most technical analysis of Arcturus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Arcturus from various momentum indicators to cycle indicators. When you analyze Arcturus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.02) | |||
Market Risk Adjusted Performance | (0.06) | |||
Mean Deviation | 3.22 | |||
Coefficient Of Variation | (2,158) | |||
Standard Deviation | 4.02 | |||
Variance | 16.16 | |||
Information Ratio | (0.07) | |||
Jensen Alpha | (0.41) | |||
Total Risk Alpha | (0.71) | |||
Treynor Ratio | (0.07) | |||
Maximum Drawdown | 18.16 | |||
Value At Risk | (7.02) | |||
Potential Upside | 6.02 | |||
Skewness | (0.14) | |||
Kurtosis | (0.32) |
Arcturus Therapeutics April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Arcturus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 19,306 | ||
Daily Balance Of Power | 0.49 | ||
Rate Of Daily Change | 1.03 | ||
Day Median Price | 27.92 | ||
Day Typical Price | 27.92 | ||
Price Action Indicator | 0.45 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcturus Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Arcturus Stock analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 6.264 | Quarterly Revenue Growth (0.81) | Return On Assets (0.11) | Return On Equity (0.11) |
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.